Cargando…

BCLAF1 induces cisplatin resistance in lung cancer cells

Treatment for non-small cell lung cancer (NSCLC) remains challenging due to frequent recurrence and the development of resistance to platinum-based chemotherapy. The mechanism underlying NSCLC chemoresistance remains unclear. The present study aimed to investigate the mechanism of cisplatin resistan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jiang, Tao, Liu, Bingjie, Wu, Dongping, Zhang, Feng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	D.A. Spandidos 2020
Materias:	Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7500056/ https://www.ncbi.nlm.nih.gov/pubmed/32968449 http://dx.doi.org/10.3892/ol.2020.12090

Ejemplares similares

In Search of a Function for BCLAF1
por: Sarras, Haya, et al.
Publicado: (2010)

Function of BCLAF1 in human disease
por: Yu, Zongdong, et al.
Publicado: (2022)

Role of BCLAF‐1 in PD‐L1 stabilization in response to ionizing irradiation
por: Ma, Zhao, et al.
Publicado: (2021)

Bclaf1 promotes angiogenesis by regulating HIF-1α transcription in hepatocellular carcinoma
por: Wen, Ying, et al.
Publicado: (2018)

miR-194-5p/BCLAF1 deregulation in AML tumorigenesis
por: Dell'Aversana, C, et al.
Publicado: (2017)

Bclaf1 critically regulates the type I interferon response and is degraded by alphaherpesvirus US3
por: Qin, Chao, et al.
Publicado: (2019)

Erratum: miR-194-5p/BCLAF1 deregulation in AML tumorigenesis
por: Dell'Aversana, C, et al.
Publicado: (2017)

Hypoxia-induced autophagy mediates cisplatin resistance in lung cancer cells
por: Wu, Hui-Mei, et al.
Publicado: (2015)

The long noncoding RNA lncCIRBIL disrupts the nuclear translocation of Bclaf1 alleviating cardiac ischemia–reperfusion injury
por: Zhang, Yang, et al.
Publicado: (2021)

TET2–BCLAF1 transcription repression complex epigenetically regulates the expression of colorectal cancer gene Ascl2 via methylation of its promoter
por: Shang, Yangyang, et al.
Publicado: (2022)

Ginsenoside Compound K Regulates HIF-1α-Mediated Glycolysis Through Bclaf1 to Inhibit the Proliferation of Human Liver Cancer Cells
por: Zhang, Silin, et al.
Publicado: (2020)

Identifying and characterising Thrap3, Bclaf1 and Erh interactions using cross-linking mass spectrometry
por: Shcherbakova, Liudmila, et al.
Publicado: (2023)

Role of Bclaf1 in Promoting Adrenocortical Carcinoma Proliferation: A Study Combining the Use of Bioinformatics and Molecular Events
por: Zhou, Hui, et al.
Publicado: (2021)

GLIPR1 modulates the response of cisplatin-resistant human lung cancer cells to cisplatin
por: Gong, Xin, et al.
Publicado: (2017)

RAG-Mediated DNA Breaks Attenuate PU.1 Activity in Early B Cells through Activation of a SPIC-BCLAF1 Complex
por: Soodgupta, Deepti, et al.
Publicado: (2019)

LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA
por: Chen, Mingwei, et al.
Publicado: (2020)

Thioridazine Enhances Cisplatin-Induced DNA Damage in Cisplatin-Resistant Human Lung Cancer Cells
por: Luo, Yuanyuan, et al.
Publicado: (2022)

NEAT1 upregulates EGCG-induced CTR1 to enhance cisplatin sensitivity in lung cancer cells
por: Jiang, Pan, et al.
Publicado: (2016)

Correction for: LncRNA PVT1 accelerates malignant phenotypes of bladder cancer cells by modulating miR-194-5p/BCLAF1 axis as a ceRNA
por: Chen, Mingwei, et al.
Publicado: (2021)

FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer
por: He, Lingfeng, et al.
Publicado: (2017)

FEN1 promotes tumor progression and confers cisplatin resistance in non‐small‐cell lung cancer
por: He, Lingfeng, et al.
Publicado: (2017)

Apurinic endonuclease 1 promotes the cisplatin resistance of lung cancer cells by inducing Parkin-mediated mitophagy
por: Li, Zheng, et al.
Publicado: (2019)

BCLAF1 is a radiation-induced H2AX-interacting partner involved in γH2AX-mediated regulation of apoptosis and DNA repair
por: Lee, Y Y, et al.
Publicado: (2012)

miR-133b reverses cisplatin resistance by targeting GSTP1 in cisplatin-resistant lung cancer cells
por: Lin, Chen, et al.
Publicado: (2018)

Cry2 Is Critical for Circadian Regulation of Myogenic Differentiation by Bclaf1-Mediated mRNA Stabilization of Cyclin D1 and Tmem176b
por: Lowe, Matthew, et al.
Publicado: (2018)

The RNA processing factors THRAP3 and BCLAF1 promote the DNA damage response through selective mRNA splicing and nuclear export
por: Vohhodina, Jekaterina, et al.
Publicado: (2017)

PD‐0332991 combined with cisplatin inhibits nonsmall cell lung cancer and reversal of cisplatin resistance
por: Liu, Minghui, et al.
Publicado: (2021)

Expression of Ferredoxin1 in cisplatin‑resistant ovarian cancer cells confers their resistance against ferroptosis induced by cisplatin
por: Takahashi, Ryosuke, et al.
Publicado: (2023)

EHD1 confers resistance to cisplatin in non-small cell lung cancer by regulating intracellular cisplatin concentrations
por: Gao, Jing, et al.
Publicado: (2016)

Ophiopogonin B alleviates cisplatin resistance of lung cancer cells by inducing Caspase-1/GSDMD dependent pyroptosis
por: Cheng, Ziyu, et al.
Publicado: (2022)

Niclosamide enhances the cytotoxic effect of cisplatin in cisplatin-resistant human lung cancer cells via suppression of lung resistance-related protein and c-myc
por: Zuo, Yufang, et al.
Publicado: (2018)

SKA1 regulates the metastasis and cisplatin resistance of non-small cell lung cancer
por: SHEN, LIHUA, et al.
Publicado: (2016)

FOXO1 inactivation induces cisplatin resistance in bladder cancer
por: Ide, Hiroki, et al.
Publicado: (2020)

Cytoplasmic RAP1 mediates cisplatin resistance of non-small cell lung cancer
por: Xiao, Lu, et al.
Publicado: (2017)

Upregulation of Coxsackie Adenovirus Receptor Sensitizes Cisplatin-Resistant Lung Cancer Cells to CRAd-Induced Inhibition
por: Sakhawat, Ali, et al.
Publicado: (2017)

Resensitization of cisplatin resistance ovarian cancer cells to cisplatin through pretreatment with low‐dose fraction radiation
por: Zhao, Lili, et al.
Publicado: (2019)

Up-regulation of fas reverses cisplatin resistance of human small cell lung cancer cells
por: Wu, Wei, et al.
Publicado: (2010)

Reduced expression of Bax in small cell lung cancer cells is not sufficient to induce cisplatin-resistance
por: Biagosch, J, et al.
Publicado: (2010)

Cisplatin-resistant lung cancer cell–derived exosomes increase cisplatin resistance of recipient cells in exosomal miR-100–5p-dependent manner
por: Qin, Xiaobing, et al.
Publicado: (2017)

Ischemia and reperfusion injury combined with cisplatin induces immunogenic cell death in lung cancer cells
por: Zhang, Shuai, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0hn9lpt0tqd3bqe4bbkrkuboip